In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut from the market. In Drugs, Cash and Key Handshakes, Robin Feldman shines a light in to the dark edges of the pharmaceutical market to expose an online of shadowy offers in which higher-priced medications receive beneficial treatment and individuals are channeled toward the priciest medicines. At the guts of this web are the highly secretive middle players who create coverage amounts for individuals and negotiate with medication companies. By offering lucrative obligations to these middle players (as well as to doctors and private hospitals), medication companies ensure that inexpensive drugs never gain grip. This technique of perverse bonuses has delivered the type of exorbitant drug prices-and profits-that everyone loves except for those who settle the bills.